What Is Perimesencephalic Subarachnoid Hemorrhage?

Perimesencephalic subarachnoid hemorrhage (PMSAH) is a specific type of brain bleed in which blood collects in the cisterns surrounding the midbrain and pons, with no aneurysm found on vascular imaging. It accounts for roughly 5% of all spontaneous subarachnoid hemorrhages and carries a dramatically better prognosis than the aneurysmal kind, which is the type most people picture when they hear “brain hemorrhage.” Despite the frightening diagnosis, most people with PMSAH recover fully, and life expectancy appears to be normal. The condition is genuinely distinct from other forms of subarachnoid hemorrhage, though the diagnostic workup and the weeks that follow can still be stressful and confusing.

How It Differs From Other Brain Bleeds

A subarachnoid hemorrhage (SAH) means blood has leaked into the fluid-filled space surrounding the brain. About 85% of the time, that bleeding comes from a ruptured aneurysm, a weak spot in an artery wall that balloons and eventually bursts. Aneurysmal SAH is a medical emergency with high rates of disability and death. PMSAH is the other end of the spectrum. The blood sits in a very characteristic location: the cisterns just in front of and around the brainstem, centered near the midbrain. It does not spread into the large fissures between the brain’s hemispheres, and it does not fill the ventricles with large clots.

That pattern matters because it was the key observation that led researchers in the early 1990s to propose that PMSAH should be treated as a completely separate entity from aneurysmal SAH. A landmark study described patients with this specific bleeding pattern and a normal angiogram, arguing they should be excluded from future treatment trials for SAH because their clinical course was so different.

There is also a middle category that creates confusion. Some patients have a non-aneurysmal bleed, but the blood distribution is more diffuse and does not fit the perimesencephalic pattern. These “non-perimesencephalic, non-aneurysmal” hemorrhages behave more aggressively, with higher rates of hydrocephalus, vasospasm, and rebleeding than PMSAH.¹ In one early series, the non-perimesencephalic group had rebleeds, hydrocephalus, and delayed brain injury, while the perimesencephalic group had essentially none of those complications during follow-up.² The distinction between perimesencephalic and non-perimesencephalic patterns on the initial CT scan is one of the most clinically meaningful classification decisions a neurologist makes after a subarachnoid hemorrhage with negative angiography.

What Causes It

The honest answer is that no one has definitively proven the source of bleeding. The leading hypothesis, and the one most experts accept, is that the bleed is venous in origin rather than arterial. The reasoning goes like this: the bleeding is always limited in extent, the clinical presentation is mild, vasospasm is rare, and rebleeding almost never happens. All of those features point away from a ruptured artery and toward a small vein or capillary giving way under pressure.³

Some researchers have looked deeper into the brain’s venous plumbing for anatomical clues. A meta-analysis found that patients with PMSAH were much more likely to have a primitive (underdeveloped) variant of a deep cerebral vein called the basal vein of Rosenthal compared to patients whose SAH was caused by an aneurysm. Roughly half of PMSAH patients had this primitive drainage pattern in at least one hemisphere, versus about a fifth of aneurysmal SAH patients.⁴ A primitive drainage variant means the vein takes an unusual route and may be more susceptible to pressure changes. The idea is that if blood drains from the brainstem region through fragile, underdeveloped channels, those channels might rupture more easily.

Not everyone agrees with this interpretation. At least one large controlled study found no association between primitive basal vein variants and PMSAH after adjusting for age and sex.⁵ So while the venous theory is the most popular explanation, it remains a hypothesis rather than a proven mechanism. The underlying cause might also vary from patient to patient, with venous anatomy playing a role in some cases and other factors in others.

Physical Exertion as a Trigger

One of the more distinctive features of PMSAH is its relationship with physical effort. In a study comparing triggers across subtypes of non-aneurysmal SAH, about four out of five PMSAH cases were triggered during physical exertion, compared to only about one in six of the non-perimesencephalic cases.⁶ That is a striking difference. The types of exertion reported include swimming, golfing, heavy lifting, and bending forward during exercise.⁷

The connection fits neatly with the venous hypothesis. Activities that involve straining against a closed airway, sometimes called a Valsalva-type maneuver, temporarily spike pressure inside the chest. That elevated chest pressure impedes blood return from the brain through the jugular veins, momentarily raising venous pressure inside the skull. If a fragile vein or capillary near the brainstem is already vulnerable, that pressure surge could be enough to cause a rupture.⁷ One case report specifically linked PMSAH to hypoxic swim training, where a swimmer practiced breath-holding laps, suggesting that the acute venous congestion from breath-holding was the triggering event.⁸

For people who have had PMSAH, the natural question is whether they need to avoid exercise permanently. The evidence here is reassuring: rebleeding after PMSAH is extremely rare, and there are no formal guidelines restricting physical activity long-term. Most neurologists allow a gradual return to exercise once the acute phase has resolved, though individual advice will depend on the specifics of your case.

How Doctors Confirm the Diagnosis

The diagnostic workup for PMSAH is a process of elimination. The first step is a CT scan, which shows the subarachnoid blood and, critically, its distribution pattern. If the blood is centered in the perimesencephalic cisterns and does not extend significantly into the Sylvian fissures or interhemispheric fissure, the scan raises the possibility of PMSAH. But that pattern alone is not enough. Posterior circulation aneurysms can occasionally mimic the perimesencephalic distribution early on, which means the next step is vascular imaging to rule out an aneurysm.⁹

CT angiography (CTA) is now the first-line vascular study in most centers. It is fast, non-invasive, and highly accurate. In one study, no patients with a true perimesencephalic bleeding pattern were found to have an aneurysm on either CTA or the gold-standard catheter angiography.¹⁰ A systematic review calculated the negative predictive value of CTA at about 99%, meaning that when CTA says there is no aneurysm in a patient with a perimesencephalic pattern, it is almost always correct.¹¹

The trickier question is whether patients also need a catheter-based digital subtraction angiography (DSA), which is the gold standard for finding aneurysms but carries its own risks. DSA involves threading a catheter through the groin artery up into the brain’s blood vessels, and complications including stroke occur in roughly 1-2% of procedures.¹¹ That systematic review concluded that DSA after a negative CTA may not add diagnostic value in PMSAH patients and could actually lead to net harm because of procedural risks. Practice is shifting, but many centers still perform at least one DSA, especially if there is any ambiguity in the blood distribution.

The Debate Over Repeat Angiography

Even after a negative CTA and a negative initial DSA, some hospitals routinely schedule a second angiogram days or weeks later to make absolutely sure they have not missed a hidden aneurysm. This practice is falling out of favor for PMSAH specifically. One study found that repeat angiography did not reveal any pathology in the perimesencephalic group, whereas it did find aneurysms in patients with the more diffuse, non-perimesencephalic bleeding pattern.¹²

A more recent study took a detailed look at this question. Among patients with typical PMSAH who underwent a second DSA, two small basilar artery aneurysms were found that had not been visible on earlier imaging, but neither led to a change in treatment, and the procedure itself caused complications in 2% of cases, including a cerebellar infarct.¹³ The authors concluded that the diagnostic benefit of a repeat DSA in typical PMSAH is low, with no clear therapeutic impact and a real risk of procedural harm. If you are told you need a repeat angiogram, it is reasonable to ask your doctor whether the blood pattern on your CT was truly perimesencephalic or whether there were features that make the team less certain.

When the Pattern Fools You

PMSAH is defined by a specific bleeding pattern plus a negative angiogram, but the pattern alone is not a guarantee. A study comparing PMSAH to bleeds caused by posterior circulation aneurysms found that about 17% of ruptured posterior circulation aneurysms initially presented with a bleeding pattern that looked perimesencephalic on the first CT scan.¹⁴ That is why vascular imaging is mandatory even when the blood pattern looks classic. You cannot diagnose PMSAH from the CT alone.

In rare cases, the culprit turns out to be something nobody expected. There is at least one documented case of a spinal artery aneurysm far down in the thoracic spine causing bleeding that showed up in the perimesencephalic cisterns.¹⁵ Cases like this are extremely unusual, but they underline why the full diagnostic evaluation matters. Another potential mimic is cerebral venous sinus thrombosis, where a blood clot in one of the brain’s large drainage veins raises venous pressure enough to cause perimesencephalic-pattern bleeding.³ Sinus thrombosis requires its own specific treatment, so it is important that doctors consider it in the workup.

Complications During the Hospital Stay

The whole reason PMSAH is treated as a distinct entity is that complications are far less common than in aneurysmal SAH. But “far less common” is not the same as zero. In one cohort, about 14% of PMSAH patients developed vasospasm (narrowing of brain arteries that can threaten blood flow), about a quarter developed some degree of hydrocephalus (buildup of cerebrospinal fluid), and about 8% had delayed cerebral ischemia.¹⁶ Despite these complications, most patients in that study were discharged in excellent functional condition.

The vasospasm picture is worth unpacking. In a study that separated PMSAH cases by whether an underlying aneurysm was ultimately found, symptomatic vasospasm occurred in 40% of those with a hidden aneurysm but only about 3% of truly non-aneurysmal cases.¹⁷ Most vasospasm detected in PMSAH patients is asymptomatic, meaning it shows up on imaging but does not cause any clinical problems. When symptoms do occur, they tend to be mild compared to what happens after aneurysmal rupture.

Hydrocephalus in PMSAH is usually manageable but can occasionally become a serious issue. Compared to non-perimesencephalic SAH, where about half of patients develop hydrocephalus, the rate in PMSAH hovers around 10%, and need for permanent cerebrospinal fluid drainage is rare.¹⁸ A small case series described three PMSAH patients with heavy clot burden who developed acute hydrocephalus requiring intervention, but this scenario appears to be uncommon.¹⁹

What the Hospital Stay Looks Like

Hospital management of PMSAH varies considerably depending on the amount of blood seen on the initial scan and how the patient is doing clinically. A national survey of treatment centers found that about half admit patients with a minor bleed to an intensive care unit, while the other half use an intermediate-level monitoring unit or even a regular ward. When the bleed is more extensive, roughly 70% of centers use the ICU.²⁰ Blood pressure monitoring also scales with severity: invasive arterial line monitoring is standard for heavier bleeds but considered unnecessary by many centers for small ones.

Hospital stays for PMSAH are typically shorter than for aneurysmal SAH, and the level of intervention is lower. There is no aneurysm to clip or coil, so the surgical procedures that define aneurysmal SAH management are not needed. The focus is on monitoring for the rare complication, managing headache (which can be severe in the first few days), and completing the diagnostic workup to confirm there really is no aneurysm.

Long-Term Prognosis and Life Expectancy

The long-term outlook after PMSAH is remarkably good. A study specifically examining life expectancy found that PMSAH patients have a normal lifespan and are not at risk for rebleeding.²¹ Recurrence is documented in the medical literature but is described as extremely rare.²²

Functional outcomes are also favorable compared to other types of SAH. In one cohort, about 84% of PMSAH patients returned to work within six months, and roughly half returned to their previous position and workload.²³ Those are encouraging numbers, but the flip side is also real: more than half of working patients did not fully return to their previous level of employment at six months, and a meaningful minority report lasting limitations.

The Fatigue Problem Nobody Warns You About

If you look only at the standard neurological exam and imaging, most PMSAH patients appear to recover completely. But when researchers dug deeper with detailed questionnaires and cognitive testing, a less tidy picture emerged. About a third of PMSAH patients still report significant fatigue five years after the bleed.²⁴ This is not ordinary tiredness. The fatigued patients had significantly worse quality of life, participated less in social and daily activities, and were more likely to struggle with depression and anxiety.

Cognitive testing tells a similar story. Patients who reported fatigue also scored lower on objective tests of thinking speed, memory, and attention.²⁵ A broader review of the literature confirmed that while the risk of complications is low and outcomes are better than after aneurysmal SAH, not all PMSAH patients return to their pre-bleed functional status, and more comprehensive neuropsychological testing has identified deficits across a range of cognitive domains at long-term follow-up.²⁶

This gap between the medical prognosis and the lived experience is one of the most underappreciated aspects of PMSAH. Patients are often told “you had the best kind of brain bleed,” which is true in relative terms but can feel dismissive when you are still dealing with crushing fatigue or brain fog months later. If you recognize yourself in that description, it is worth asking for a formal neuropsychological evaluation and connecting with a rehabilitation specialist. The fatigue and cognitive difficulties after PMSAH appear to be real, they show up on objective testing, and they do respond to targeted rehabilitation strategies, even if the medical literature on treatment is still thin.

Rare Triggers and Unusual Presentations

Beyond the physical exertion link, occasional case reports have connected PMSAH to situations that create sudden venous congestion. Intracranial venous sinus thrombosis has been identified as a cause in some patients, where a clot in a major drainage vein raises pressure throughout the brain’s venous system.³ In those patients, the treatment is anticoagulation for the thrombosis, which is the opposite of what you would do for most brain bleeds. Getting the diagnosis right matters enormously.

The typical patient with PMSAH presents with a sudden-onset headache, often described as the worst headache of their life, but in a much better clinical state than patients with aneurysmal SAH. Many are fully alert and neurologically normal at the time of arrival. Loss of consciousness, seizures, and focal neurological deficits are unusual. When those features are present, doctors become more suspicious that an aneurysm or other structural lesion has been missed, even if the bleeding pattern looks perimesencephalic on the initial scan. The combination of a classic perimesencephalic blood distribution, an alert patient, and a clean angiogram is what gives doctors the confidence to reclassify the event from a terrifying emergency into a condition with an excellent expected outcome.